Cargando cotizaciones...
Previsión
No hay datos de analistas disponibles para esta empresa.
Noticias Ir al feed de noticias
Teraplast records revenue decline and Q1 net loss
Teraplast reports a 6% decline in revenue to 236 million RON for Q1 2026, an EBITDA of 8.9 million RON (down 58%) and a net loss of 10.6 million RON versus a profit of 1.2 million RON a year earlier. Severe winter weather, geopolitical tensions and delayed public investment projects weighed on results, while gross margin rose to 40%. Management cites operational efficiency measures and strategic integration as countermeasures and expects support from potential EU funds and a recovery after the elections in Hungary. » Más en de.investing.com
Teraplast Group reports 21% revenue increase in Q4 2025 and return to profit
Teraplast Group continued its growth in Q4 2025: consolidated revenue rose 21% to 1,083 million RON, EBITDA climbed 75% to 86.7 million RON and the EBITDA margin improved to 8.0%. The company returned to profitability with a net profit of 1.2 million RON after a loss of 20 million RON in 2024. Production increased to 135,000 tonnes (+12%), international sales grew 60% and accounted for 34% of revenue. The share fell slightly by 1.28% to 0.422 RON after the figures were released; management plans further acquisitions and capacity expansions, including a focus on Optiplast in Croatia, and gives EPS forecasts for 2026/2027 of 2.79 and 2.94 USD respectively. » Más en de.investing.com
Teraplast reports significant revenue and earnings growth in Q3 2025
Teraplast increased consolidated revenue in the third quarter of 2025 by 26% to 857 million RON and raised EBITDA by 59% to 72 million RON, pushing the EBITDA margin up to 8.4%. Net profit swung from a year‑earlier loss to a profit of 6.3 million RON. The company attributes the growth to higher volumes, operational efficiency, the acquisition of Aquatica Experience Group and expansion into several European markets. Teraplast plans to continue geographic diversification, reduce debt and pursue selective M&A strategies. » Más en de.investing.com
Dividendos históricos Dividendos
Todas las métricas de dividendos Todas las métricasDescubrir activos
Los accionistas de TERAPLAST SA LN -,10 también invierten en los siguientes activos
